LID.L Regulatory News (LID)

LiDCO Group Plc

("LiDCO" or the "Company")

Appointment of French distributor

LiDCO (AIM: LID), the hemodynamic monitoring company, announces that it has signed an exclusive three year agreement with Spacelabs Healthcare SAS France to distribute LiDCO products in France. Spacelabs Healthcare SAS France is part of Spacelabs Healthcare which itself is a wholly owned subsidiary of OSI Systems (NASDAQ/OSIS).

Spacelabs Healthcare designs and manufactures advanced patient monitoring devices, anesthesia delivery and ventilation systems, diagnostic cardiology devices, software, and supplies and accessories. It employs more than 1,100 people around the world.

France is currently the fifth largest medical device market in the world, with an established adoption of hemodynamic monitoring. LiDCO's technology has never been actively promoted in France and the Board believes that there are opportunities with its minimally invasive and non-invasive technologies, in the hands of the right strategic partner, to gain share in this large market.

More information about LiDCO can be found on the Company's website www.lidco.com

Commenting on the distribution agreement, Matt Sassone, Chief Executive Officer of LiDCO, said: "This is an exciting development for our business in Europe. We are looking forward to working with Spacelabs to launch our latest monitor. It's important that we have partnered with such a credible company with an established brand and infrastructure in France, as we look to penetrate this large market."

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 ("MAR").

For further information, please contact:

About LiDCO Group Plc (www.lidco.com)

LiDCO is a supplier of non-invasive and minimally invasive hemodynamic equipment to hospitals used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimisation protocols for high risk patients in both critical care units and in the operating theatre. 

Increasingly clinical studies are showing that the optimisation of patients' hemodynamic status in high risk patients produces better outcomes and reduced hospital stay. LiDCO's computer-based technology, originally developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.

Key Products:

LiDCOunity: a hemodynamic monitor that combines the full suite of LiDCO technology (non-invasive, minimally invasive and calibrated technologies) into one platform. Designed to have the flexibility to adapt to a patient's changing acuity, the product enables clinicians to seamlessly transition between non-invasive, minimally invasive and calibrated hemodynamic monitoring. Version 2 of this software is only available on a new slim widescreen monitor and includes the optional high usage program software in selected markets.

LiDCOplus: a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness.

LiDCOrapid: a cardiac output monitor designed specifically for use in the operating theatre for fluid and drug management. The monitor enables anaesthetists to receive accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being before, during and after surgery. The LiDCOrapid provides:

· early and rapid warning of hemodynamic change to aid choice of therapeutic route: fluid or drug

· quantification of hemodynamic response guidance on effective delivery of fluids to ensure the right amount at the right time

The software incorporated into LiDCOrapid allows the LiDCOrapid monitor to co-display Medtronic's level of consciousness parameter ('BISTM')* and add the convenience of CNSystem's continuous non-invasive blood pressure monitoring ('CNAP')**. This addresses a growing requirement for non-invasive monitoring solutions that are more comprehensive and can effectively replace multiple single parameter monitors. 

LiDCOview: an easy-to-use graphical display of historical LiDCOplus and LiDCOrapid hemodynamic data.

*BISTM and Bispectral Index are trademarks of Medtronic registered in the US and foreign countries.

**CNAPTM is a trademark of CNSystems Medizintechnik AG.

LiDCO monitors use single-patient disposables (sensors or smartcards) which provide an ongoing revenue stream.

LiDCO Distribution Network:

LiDCO sells directly to hospitals in the UK and USA and through a network of specialty critical care and anaesthesia distributors in the rest of the world.

LiDCO's headquarters are in London and its shares are traded on AIM.